Studying the effect of a new type of honey eye drop on dry eye patients

Phase 3

Conditions: dry eye syndrom.
Other disorders of lacrimal gland
H04.1

Registration Number: IRCT20220117053744N1

Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 80

Inclusion Criteria

Patients (male or female, without age limit) with dry eye syndrome (at three levels of low, moderate, and severe)
Best corrected vision greater than or equal to 9/10
Schirmer test is less than 5 mm in 5 minutes
Tear break time is less than 10 seconds

Exclusion Criteria

Patients with blepharitis disorder
Patients with meibomian gland disorder
Patients with a history of taking tetracycline for the past three months
Patients with a history of taking oral corticosteroids for the past three months
Patients with ocular surface disorders
Patients with a history of previous surgery
Patients with a history of allergies

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tear break up time (TBUT). Timepoint: 2, 4 and 6 weeks after starting treatment. Method of measurement: Clinical examination of the patient - per second.;Corneal staining. Timepoint: 2, 4 and 6 weeks after starting treatment. Method of measurement: Clinical examination of the patient with Fluorescein test.;Basic tear secretion rate. Timepoint: 2, 4 and 6 weeks after starting treatment. Method of measurement: Clinical examination of the patient - In millimeters per minute.

Secondary Outcome Measures